| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/27/2003 | WO2002095071A8 Means and methods for identifying genes and proteins involved in the prevention and/or repair of a replication error |
| 02/27/2003 | WO2002092763A3 Intron associated with myotonic dystrophy type 2 and methods of use |
| 02/27/2003 | WO2002090505A3 Multiple sequencible and ligatible structures for genomic analysis |
| 02/27/2003 | WO2002089657A3 Diagnostic markers of acute coronary syndromes and methods of use thereof |
| 02/27/2003 | WO2002088714A3 Individualization of therapy with antineoplastic agents |
| 02/27/2003 | WO2002086447A3 Method for assessing risk for cardiac dysrhythmia in a human subject |
| 02/27/2003 | WO2002086154A8 Methods for generating libraries of therapeutic bacteriophages having desired safety characteristics and methods for labeling and monitoring bacteriophages |
| 02/27/2003 | WO2002086088A3 Polymerases with charge-switch activity and methods of generating such polymerases |
| 02/27/2003 | WO2002083064A3 A method of treating cancer |
| 02/27/2003 | WO2002081638A3 Prostate cancer expression profiles |
| 02/27/2003 | WO2002081634A3 Imaging nucleic acid delivery |
| 02/27/2003 | WO2002080845A3 Novel eps8 compounds for therapy and diagnosis and methods for using same |
| 02/27/2003 | WO2002080844A3 Novel bgp compounds for therapy and diagnosis and methods for using same |
| 02/27/2003 | WO2002077748A3 Light scatteringdetermination of treatment potencies |
| 02/27/2003 | WO2002072869A3 Novel agents for replacement of nad+/nadh system in enzymatic ractions |
| 02/27/2003 | WO2002072006A3 METHODS AND REAGENTS FOR IDENTIFYING COMPOUNDS AND MUTATIONS THAT MODULATE DOPAMINE β-HYDROXYLASE ACTIVITY |
| 02/27/2003 | WO2002071040A3 Use of infrared spectroscopy in genotypic analysis |
| 02/27/2003 | WO2002068931A3 Screening for enzyme stereoselectivity utilizing mass spectrometry |
| 02/27/2003 | WO2002064839A3 Methods for the diagnosis and treatment of tumors employing the hepsin gene |
| 02/27/2003 | WO2002064815A3 33945, a human glycosyltransferase family member and uses therefor |
| 02/27/2003 | WO2002064605A3 Synthesis of chlorophenol red glucoronic acid |
| 02/27/2003 | WO2002062956A3 Chemomagnetic retrieval of cmv and cmv infected cells |
| 02/27/2003 | WO2002059259A3 Methods for discovering secreted and transmembrane proteins |
| 02/27/2003 | WO2002055725A3 Novel nucleic acids, methods and transformed cells for the modulation of gibberellin production |
| 02/27/2003 | WO2002055555A3 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same |
| 02/27/2003 | WO2002054078A3 Method for determining skin ageing in vitro |
| 02/27/2003 | WO2002053777A3 Device and method for tracking conditions in an assay |
| 02/27/2003 | WO2002053016A3 Compounds and methods for the diagnosis and treatment of babesia infection |
| 02/27/2003 | WO2002048393A3 Light-activated in vitro assay process for luciferase bioluminescence |
| 02/27/2003 | WO2002048375A3 Purified active hcv ns2/3 protease |
| 02/27/2003 | WO2002042436A3 Isolated human phosphatase proteins, nucleic acid molecules encoding them, and uses thereof |
| 02/27/2003 | WO2002036828A3 COMPOSITIONS AND SYSTEMS FOR IDENTIFYING AND COMPARING EXPRESSED GENES (mRNAs) IN EUKARYOTIC ORGANISMS |
| 02/27/2003 | WO2002034950A3 Immobilization of biopolymers to aminated substrates by direct adsorption |
| 02/27/2003 | WO2002031161A3 Regulation of human phospholipase-like enzyme |
| 02/27/2003 | WO2002030471A3 A novel system for the evaluation of the activity and/or specificity of a viral component |
| 02/27/2003 | WO2002022810A3 Combinatorial screening of mixed populations of organisms |
| 02/27/2003 | WO2002020768A3 Caveolin peptides and their use as therapeutics |
| 02/27/2003 | WO2002020767A3 G-csf analog compositions and methods |
| 02/27/2003 | WO2002016948A3 High throughput method and kit |
| 02/27/2003 | WO2002016548A8 Novel g protein-coupled receptor |
| 02/27/2003 | WO2002014555A3 Single-labeled oligonucleotide probes |
| 02/27/2003 | WO2002014553A3 A molecular vector identification system |
| 02/27/2003 | WO2002012290A8 Sid polypeptides binding to pathogenic strain of the hepatitis c virus |
| 02/27/2003 | WO2002010459A3 Three dimensional structure of paramyxovirus hemagglutinin-neuraminidases and use thereof |
| 02/27/2003 | WO2002008267A3 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 02/27/2003 | WO2002004660A3 Method for testing for inhibition of drug-metabolizing cytochrome p450 isozymes |
| 02/27/2003 | WO2002004022A8 High fidelity polymerases and uses thereof |
| 02/27/2003 | WO2002003058A3 Device and method for making electrical contact with biological cells suspended in a fluid |
| 02/27/2003 | WO2002002797A3 Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme |
| 02/27/2003 | WO2002001950A3 Transgenic mice containing targeted gene disruptions |
| 02/27/2003 | WO2002000691A3 Polynucleotides and polypeptides encoded thereby |
| 02/27/2003 | WO2001098543A3 Method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 02/27/2003 | WO2001098481A3 Renal regulatory elements and methods of use thereof |
| 02/27/2003 | WO2001098471A3 Human phosphodiesterases |
| 02/27/2003 | WO2001085924A3 MODULATION OF η-SECRETASE ACTIVITY |
| 02/27/2003 | WO2001079558A8 High-throughput screening of expressed dna libraries in filamentous fungi |
| 02/27/2003 | WO2001079555A3 Roles of jak/stat family members in tolerance induction |
| 02/27/2003 | WO2001075164A3 Rna sequence-specific mediators of rna interference |
| 02/27/2003 | WO2001066797A3 Multiplex hybridization system for identification of pathogenic mycobacterium and method of use |
| 02/27/2003 | WO2001061050A3 Methods and compositions for the identification, assessment, prevention and therapy of human cancers |
| 02/27/2003 | US20030041355 Method of humanizing plant cDNA |
| 02/27/2003 | US20030041345 Nucleotide sequences coding enzymatic polypeptide for use in the propagation of plants |
| 02/27/2003 | US20030040620 Method of producing a DNA library using positional amplification |
| 02/27/2003 | US20030040607 Hematopoietic cell E-selection/L-selectin ligand polypeptides and methods of use thereof |
| 02/27/2003 | US20030040603 Purified mammalian CTLA-8 antigens and related reagents |
| 02/27/2003 | US20030040525 Inhibition of human telomerase by a G-quadruplex-interaction compound |
| 02/27/2003 | US20030040505 Synthetic phospholipids to ameliorate atherosclerosis and other inflammatory conditions |
| 02/27/2003 | US20030040500 Replication incompetent herpes virus vectors |
| 02/27/2003 | US20030040497 Compositions and methods for non-parenteral delivery of oligonucleotides |
| 02/27/2003 | US20030040495 Collecting tissue; determining amount of mitochondrial DNA damage in tissue; comparing the amount of mitochondrial DNA damage in tissue of interest to the amount of mitochondrial DNA damage in tissue of interest from a control |
| 02/27/2003 | US20030040476 EAG gene |
| 02/27/2003 | US20030040473 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030040463 Reducing pathological neovascularization in a human by administering to the human an agent capable of interfering with Ang2-mediated biological effects |
| 02/27/2003 | US20030040461 Providing a cell expressing Bruton's Tyrosine Kinase; contacting cell expressing Bruton's Tyrosine Kinase with a test compound; determining whether test compound modulates the activity of Bruton's Tyrosine Kinase |
| 02/27/2003 | US20030040115 Lytic reagent composition for determination of nucleated red blood cells |
| 02/27/2003 | US20030040114 Screening for modulators of ribozyme activity; obtain sample containing ribozyme, incubate with modulator, monitor sample for adjustment in ribozyme activity, adjustment in activity indicates modulator |
| 02/27/2003 | US20030040111 Differentiated cells suitable for human therapy |
| 02/27/2003 | US20030040107 Apparatus for use accurate genetic analysis associated with microarrays |
| 02/27/2003 | US20030040096 Nucleotide sequences coding enzmatic polypeptide for use in the treatment of acquired immunodeficiency syndromes, nervous system and ischemic injury disorders |
| 02/27/2003 | US20030040078 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative and tumor disorders |
| 02/27/2003 | US20030040076 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030040071 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative and tumor disorders |
| 02/27/2003 | US20030040054 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030040053 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cell proliferative disorders and tumors |
| 02/27/2003 | US20030040052 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of human cancers |
| 02/27/2003 | US20030040050 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory disorders |
| 02/27/2003 | US20030040048 Nucleotide sequences coding polypeptide for use in the treatment of cancer, heart and viral diseases |
| 02/27/2003 | US20030040045 Mammalian sweet taste receptors |
| 02/27/2003 | US20030040041 Nucleotide sequences coding polypeptide for use in the treatment of scarring and/or fibrosis |
| 02/27/2003 | US20030040039 Nucleotide sequences coding polypeptide for use in the treatment of diabetes |
| 02/27/2003 | US20030040038 Screening effect of modulators on target cells; obtain cell, transform with expresion vector coding activator and preferential protein, monitor cell activity, compare to control |
| 02/27/2003 | US20030040034 Reflective disc assay devices, systems and methods |
| 02/27/2003 | US20030040032 Monitoring efficacy of bactericide; obtain bacterial sample, incubate with bacatericide, measure concentration of viabile bacteria at various times, compare to concentration of bacteria at start |
| 02/27/2003 | US20030040030 Homocysteine assay |
| 02/27/2003 | US20030040022 Dopamine receptors and genes |
| 02/27/2003 | US20030040021 Apparatus for use in the detection of preferential particles in sample |
| 02/27/2003 | US20030040019 Biological material chip |
| 02/27/2003 | US20030040015 Detection of moduators of enzyme activity; obtain sample containing oxidoreductase, incubate with modulator, monitor adjustment in enzyme activity |
| 02/27/2003 | US20030040012 Method of detecting protein-protein interaction |
| 02/27/2003 | US20030040008 Immobilization of preferential particles on solid support; generate solid support, incubate with reactive cyclodextrin, join cyclodextrin to solid support, expose to preferential particle, join to cyclodextrin support |